A Phase 1b/2 Study of Safety and Efficacy of Rociletinib in Combination With MPDL3280A in Patients With Advanced or Metastatic EGFR-mutant NSCLC
Clinical trial NCT02630186 · TERMINATED
Trial details
- NCT number
- NCT02630186
- Sponsor
- Clovis Oncology, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-24
- Primary completion
- 2017-09-05
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.